I think BMK did some damage control today. They know their assay results will have potential, but in this market anything less than fantastic assays and the stock will get sold hard. It's very hard to get a read from todays update from BMK, if we knew how rich the assays are from that 600M from N1, we would have a clearer picture of the future share price. Todays close was at $.42, thats getting very close to what the big boys paid to get into this stock. The downside from here is most likely very minimal. If your in currently, your best bet is to probably wait it out.  I know I would. I sold this stock last week, because I only play it for short flips. I'm still angry about their last PP, so I just play it to beat it for a few pennies here and there. I know, how childish, but thats me. LOL

Al